Therefore, an in-depth study of the mechanism of NEAT1 in tumor drug resistance is of great significance in developing new treatment strategies to improve the sensitivity of ovarian cancer patients to chemotherapy. This evidence concerns the gene NEAT1 and ovarian cancer.